Promotion the Immunogenicity of Chitosan Nanoparticle-Based Influenza Vaccine Using Hemokinin-1

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

SHAHSAVANDI SHAHLA; EBRAHIMI MOHAMMAD MAJID; Samiee Mohammad Reza

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Arak University Medical Sciences Year:2018 | Volume:21 | Issue:3 (132) Page(s): 65-74

Download Full-Text

Persian Verion

View:

483

Download:

Cites:

Information Journal Paper

Title

Promotion the Immunogenicity of Chitosan Nanoparticle-Based Influenza Vaccine Using Hemokinin-1

Author(s)

SHAHSAVANDI SHAHLA | EBRAHIMI MOHAMMAD MAJID | Samiee Mohammad Reza | Issue Writer Certificate

Keywords

Hemokinin-1Q1

InfluenzaQ1

NanoparticlesQ1

Abstract

Background and Aim: The inactivated vaccines are formulated with adjuvant to direct the host immune responses and also increase stability of the antigen. In recent years, the development of biological adjuvants and the evaluation of their ability in elicitation of immune responses against Influenza virus have been considered. Hemokinin-1 (HK-1) activates T and B cells for differentiation into plasma cells, and antibody production. In this study, the effect of HK-1 for inducing humoral immune response against Influenza chitosan based-nano vaccine was investigated. Materials and Methods: Chitosan nanoparticle containing inactivated Influenza antigen and chitosan nanoparticle containing the inactivated antigen formulated with HK-1 were prepared. Immune response following Influenza Nanoparticles vaccinations with and without the adjuvant was assessed in SPF chickens after prime and boost immunizations. Specific antibody levels against Influenza were evaluated in serum samples of treatment and control groups by serological tests. Findings: The chickens immunized with the HK-1 adjuvanted nano vaccine produced higher specific antibody titers that were sustained until the end of experiment comparable either with inactivated antigen alone or the H9N2 Nanoparticles without HK-1 adjuvant. Administration of boosting had no effect on the enhancing of antibody titer. Conclusion: The data show that the chitosan Nanoparticles provide better absorption conditions and more stability and release of the Influenza antigen in the presence of HK-1 biological adjuvant.

Cites

No record.

References

No record.

Cite

APA: Copy

SHAHSAVANDI, SHAHLA, EBRAHIMI, MOHAMMAD MAJID, & Samiee, Mohammad Reza. (2018). Promotion the Immunogenicity of Chitosan Nanoparticle-Based Influenza Vaccine Using Hemokinin-1. ARAK MEDICAL UNIVERSITY JOURNAL (AMUJ), 21(3 (132) ), 65-74. SID. https://sid.ir/paper/69888/en

Vancouver: Copy

SHAHSAVANDI SHAHLA, EBRAHIMI MOHAMMAD MAJID, Samiee Mohammad Reza. Promotion the Immunogenicity of Chitosan Nanoparticle-Based Influenza Vaccine Using Hemokinin-1. ARAK MEDICAL UNIVERSITY JOURNAL (AMUJ)[Internet]. 2018;21(3 (132) ):65-74. Available from: https://sid.ir/paper/69888/en

IEEE: Copy

SHAHLA SHAHSAVANDI, MOHAMMAD MAJID EBRAHIMI, and Mohammad Reza Samiee, “Promotion the Immunogenicity of Chitosan Nanoparticle-Based Influenza Vaccine Using Hemokinin-1,” ARAK MEDICAL UNIVERSITY JOURNAL (AMUJ), vol. 21, no. 3 (132) , pp. 65–74, 2018, [Online]. Available: https://sid.ir/paper/69888/en

Related Journal Papers